PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CRNX vs. QQQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CRNX and QQQ is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

CRNX vs. QQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Crinetics Pharmaceuticals, Inc. (CRNX) and Invesco QQQ (QQQ). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-30.77%
13.48%
CRNX
QQQ

Key characteristics

Sharpe Ratio

CRNX:

-0.05

QQQ:

1.40

Sortino Ratio

CRNX:

0.30

QQQ:

1.90

Omega Ratio

CRNX:

1.04

QQQ:

1.25

Calmar Ratio

CRNX:

-0.06

QQQ:

1.88

Martin Ratio

CRNX:

-0.17

QQQ:

6.51

Ulcer Index

CRNX:

14.73%

QQQ:

3.92%

Daily Std Dev

CRNX:

51.71%

QQQ:

18.23%

Max Drawdown

CRNX:

-68.70%

QQQ:

-82.98%

Current Drawdown

CRNX:

-39.27%

QQQ:

-0.42%

Returns By Period

In the year-to-date period, CRNX achieves a -27.91% return, which is significantly lower than QQQ's 5.09% return.


CRNX

YTD

-27.91%

1M

-4.90%

6M

-30.77%

1Y

1.26%

5Y*

9.38%

10Y*

N/A

QQQ

YTD

5.09%

1M

2.37%

6M

13.48%

1Y

26.98%

5Y*

19.29%

10Y*

18.32%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CRNX vs. QQQ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRNX
The Risk-Adjusted Performance Rank of CRNX is 4242
Overall Rank
The Sharpe Ratio Rank of CRNX is 4343
Sharpe Ratio Rank
The Sortino Ratio Rank of CRNX is 4141
Sortino Ratio Rank
The Omega Ratio Rank of CRNX is 3939
Omega Ratio Rank
The Calmar Ratio Rank of CRNX is 4242
Calmar Ratio Rank
The Martin Ratio Rank of CRNX is 4242
Martin Ratio Rank

QQQ
The Risk-Adjusted Performance Rank of QQQ is 5858
Overall Rank
The Sharpe Ratio Rank of QQQ is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of QQQ is 5555
Sortino Ratio Rank
The Omega Ratio Rank of QQQ is 5858
Omega Ratio Rank
The Calmar Ratio Rank of QQQ is 6262
Calmar Ratio Rank
The Martin Ratio Rank of QQQ is 5959
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CRNX vs. QQQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Crinetics Pharmaceuticals, Inc. (CRNX) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CRNX, currently valued at -0.05, compared to the broader market-2.000.002.00-0.051.40
The chart of Sortino ratio for CRNX, currently valued at 0.30, compared to the broader market-4.00-2.000.002.004.006.000.301.90
The chart of Omega ratio for CRNX, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.25
The chart of Calmar ratio for CRNX, currently valued at -0.06, compared to the broader market0.002.004.006.00-0.061.88
The chart of Martin ratio for CRNX, currently valued at -0.17, compared to the broader market-10.000.0010.0020.0030.00-0.176.51
CRNX
QQQ

The current CRNX Sharpe Ratio is -0.05, which is lower than the QQQ Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of CRNX and QQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
-0.05
1.40
CRNX
QQQ

Dividends

CRNX vs. QQQ - Dividend Comparison

CRNX has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.53%.


TTM20242023202220212020201920182017201620152014
CRNX
Crinetics Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
QQQ
Invesco QQQ
0.53%0.56%0.62%0.80%0.43%0.55%0.74%0.91%0.84%1.06%0.99%1.41%

Drawdowns

CRNX vs. QQQ - Drawdown Comparison

The maximum CRNX drawdown since its inception was -68.70%, smaller than the maximum QQQ drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for CRNX and QQQ. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-39.27%
-0.42%
CRNX
QQQ

Volatility

CRNX vs. QQQ - Volatility Comparison

Crinetics Pharmaceuticals, Inc. (CRNX) has a higher volatility of 10.86% compared to Invesco QQQ (QQQ) at 4.70%. This indicates that CRNX's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
10.86%
4.70%
CRNX
QQQ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab